Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20458035 | 0.96 | ALDH1A1 (0.34) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL20282350 | 0.96 | ALDH1A1 (0.34) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL18879809 | 0.95 | ALDH1A1 (0.33) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL22017860 | 0.95 | ALDH1A1 (0.33) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL22753313 | 0.94 | ALDH1A1 (0.34) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL17451742 | 0.93 | L3MBTL1 (0.33) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL25137577 | 0.93 | KDM4E (0.31) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL20416487 | 0.92 | PTGER1 (0.32) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL22408822 | 0.91 | ALDH1A1 (0.35) | ALDH1A1HPGDKDM4EMAPTNPSR1 | |
| SCHEMBL17451743 | 0.90 | ALDH1A1 (0.36) | ALDH1A1HPGDKDM4EMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11011709-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-05-18 | — | — | US | disclosed |
| US-10608186-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-31 | — | — | US | disclosed |
| US-20180102487-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-12 | — | — | US | disclosed |
| US-20180076393-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11011709-B2 | Organic electroluminescent materials and devices | OCIAD1, RPS8, LMNB1 | ALDH1A1 1344/4885HPGD 2291/4885KDM4E 4281/4885 |
| US-20180102487-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, LMNB1, RPS8 | ALDH1A1 1345/4885HPGD 2226/4885KDM4E 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.